Carboxylesterases - Ddetoxifying enzymes and targets for drug therapy

被引:125
作者
Potter, PM
Wadkins, RM
机构
[1] St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA
[2] Univ Mississippi, Dept Chem & Biochem, University, MS 38677 USA
关键词
carboxylesterase; drug metabolism; enzyme structure; inhibitor;
D O I
10.2174/092986706776360969
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Carboxylesterases (CE) are ubiquitous enzymes responsible for the detoxification of xenobiotics. Many therapeutically useful drugs are metabolized by these proteins which impacts upon the efficiency of drug treatment. In some instances, CEs convert inactive prodrugs to active metabolites, a process that is essential for biological activity. Such compounds include the anticancer agents CPT-11 (3) and capecitabine (4), the antibiotics Ceftin (9) and Vantin, as well as the illicit street drug heroin (6). However, more commonly, CEs hydrolyze many esteriried drugs to inactive products that are then excreted. Agents such as flestolol (11). meperidine (5), lidocaine (8) and cocaine (7). are all hydrolyzed and inactivated by these enzymes. Therefore the efficacy of esterified drugs will be dependent upon the distribution and catalytic activity of different CEs. In this review. we examine the structural aspects of CEs and their roles in drug detoxification and propose that modulation of CE activity may allow for improvements in, and potentiation of, drug efficacy.
引用
收藏
页码:1045 / 1054
页数:10
相关论文
共 59 条
[51]   THE SYNTHESIS OF FATTY-ACID ETHYL-ESTER BY CARBOXYLESTER LIPASE [J].
TSUJITA, T ;
OKUDA, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 224 (01) :57-62
[52]   Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases [J].
Wadkins, RM ;
Hyatt, JL ;
Wei, X ;
Yoon, KJP ;
Wierdl, M ;
Edwards, CC ;
Morton, CL ;
Obenauer, JC ;
Damodaran, K ;
Beroza, P ;
Danks, MK ;
Potter, PM .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (08) :2906-2915
[53]   Structural constraints affect the metabolism of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) by carboxylesterases [J].
Wadkins, RM ;
Morton, CL ;
Weeks, JK ;
Oliver, L ;
Wierdl, M ;
Danks, MK ;
Potter, PM .
MOLECULAR PHARMACOLOGY, 2001, 60 (02) :355-362
[54]   Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: Synthesis, quantitative structure-activity relationship analysis, and biological activity [J].
Wadkins, RM ;
Hyatt, JL ;
Yoon, KJP ;
Morton, CL ;
Lee, RE ;
Damodaran, K ;
Beroza, P ;
Danks, MK ;
Potter, PM .
MOLECULAR PHARMACOLOGY, 2004, 65 (06) :1336-1343
[55]   Synthesis of new carboxylesterase inhibitors and evaluation of potency and water solubility [J].
Wheelock, CE ;
Severson, TF ;
Hammock, BD .
CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (12) :1563-1572
[56]   Use of ab initio calculations to predict the biological potency of carboxylesterase inhibitors [J].
Wheelock, CE ;
Colvin, ME ;
Uemura, I ;
Olmstead, MM ;
Sanborn, JR ;
Nakagawa, Y ;
Jones, AD ;
Hammock, BD .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (25) :5576-5593
[57]   Molecular Modeling of CPT-11 metabolism by carboxylesterases (CEs): Use of pnb CE as a model [J].
Wierdl, M ;
Morton, CL ;
Nguyen, NK ;
Redinbo, MR ;
Potter, PM .
BIOCHEMISTRY, 2004, 43 (07) :1874-1882
[58]   Protein dynamics in a family of laboratory evolved thermophilic enzymes [J].
Wintrode, PL ;
Zhang, DQ ;
Vaidehi, N ;
Arnold, FH ;
Goddard, WA .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 327 (03) :745-757
[59]  
Zhang J, 1999, J PHARMACOL EXP THER, V290, P314